OTTAWA - Canada could become a global manufacturing hub for a potentially game-changing treatment of COVID-19 with the signing of a new agreement to produce Merck Canada's antiviral drug in Whitby, Ont.
OTTAWA - Merck Canada announced it plans to manufacture its oral antiviral COVID-19 drug in Canada, making the country a global hub for the production of
The study of the experimental drug found 7.3% of the treatment group were either hospitalized or died at the end of 30 days, compared with 14.1% of those getting a dummy pill